Delrieu, Loris
Hamaidia, Sieme
Montaut, Emilie
Garcia-Sandoval, Andrea Cecilia
Teste, Camille
Betton-Fraisse, Patricia
Bonnefoix, Thierry
Carras, Sylvain
Gressin, Rémy
Lefebvre, Christine
Govin, Jérôme
Emadali, Anouk
Funding for this research was provided by:
French National Research Agency « Investissements d'avenir » program (ANR-15-IDEX-02, ANR-15-IDEX-02, ANR-15-IDEX-02)
French National Research Agency « CBH-EUR-GS » program (ANR-17-EURE-0003, ANR-17-EURE-0003, ANR-17-EURE-0003)
Centre Hospitalier, Université Grenoble Alpes (EPIC-AO2021, LYMPHOBET2-38RC20.076, EPIC-AO2021, LYMPHOBET2-38RC20.076, A02022, LYMPHOBET2-38RC20.076)
Aramis, oncohematology patient organization
Article History
Received: 27 June 2024
Accepted: 19 November 2024
First Online: 19 December 2024
Declarations
:
: Non-applicable.
: Non-applicable.
: The authors declare no competing interests.